National Yang Ming Chiao Tung University

Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan

Liang-Ting Lin

Yi-Jang Lee

Jyh-Cheng Chen

Te-Wei Lee

Shu-Pei Chiu

Bo-Sheng Wang

Feng-Yun Huang

Jem-Mau Lo

CAllen Chang

Bo-Sian Lin

A fluorescent fusion protein is provided. The fluorescent fusion protein of the invention comprises a first fluorescent protein with first emission wavelength, a second fluorescent protein with second excitation wavelength and second emission wavelength, and a linker peptide linking the first fusion protein and the second fusion protein, wherein the first emission wavelength overlaps the second excitation wavelength so that the second fluorescent protein exhibits the second emission wavelength after receiving energy. The fluorescent fusion protein of the invention exhibits a stronger fluorescence in the absence of bilivirdin (BV).

Fluorescent fusion protein

The invention relates to a kit for preparation of target radiopharmaceuticals, a method of using the kit to prepare target radiopharmaceuticals and use of the target radiopharmaceuticals. The target radiopharmaceuticals comprise a radio-nuclear loading on liposome and inhibit the tumor growth and metastatic progression of head and neck cancer, lung cancer and brain cancer. The radiopharmaceuticals may be used for treating the mentioned cancers.

Kit for preparation of target radiopharmaceuticals and method of using it

Growing community of inventors

Taipei, Taiwan

Liang-Ting Lin